COVID-19 is an emerging, rapidly evolving situation.
New Fogarty program addresses HIV-associated noncommunicable diseases
November / December 2019 | Volume 18, Number 6
Photo by David Rochkind for Fogarty/NIH
The new Fogarty program HIV-associated Noncommunicable
Diseases Research at LMIC Institutions aims to support locally
relevant research in critical areas of HIV-associated
Fogarty has launched an initiative designed to stimulate new
research on the interplay between HIV and noncommunicable diseases (NCDs) in developing countries. The program aims to support locally relevant research in critical areas of HIV-associated NCDs, enhance research capacity, and build a network of researchers both within and across low- and middle-income countries (LMICs) to address this critical burden.
Projects may include exploratory studies to uncover the extent to which HIV infection or drugs influence the cause and development of NCDs, and to identify and develop methods for effective diagnosis, prevention and treatment for people living with HIV (PLWH). Research teams should contain an appropriate mix of expertise to accomplish the proposed studies, including partnerships between HIV and NCD researchers who can initiate new ideas and determine the feasibility of novel approaches. Possible research areas include basic science, the aging process in PLWH, diagnostics for early detection of NCDs, behavioral studies and clinical investigations.
Four NIH institutes have partnered with Fogarty on the program, including the National Cancer Institute (NCI), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and National Institute of Mental Health (NIMH). The program will issue two-year awards for a total of up to $275,000 each.
The first round of funding is expected in mid-2020 and the next application deadline is Dec. 3, 2020.
To view Adobe PDF files,
download current, free accessible plug-ins from Adobe's website.